ETCM
CLBT icon

Evolutionary Tree Capital Management’s Cellebrite CLBT Stock Holding History

Evolutionary Tree Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.53M Buy
183,473
+33,829
+23% +$510K 4.75% 8
2025
Q4 		$2.7M Buy
149,644
+134,644
+898% +$2.42M 3.13% 15
2025
Q3 		$278K Buy
+15,000
New +$236K 0.3% 28

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Evolutionary Tree Capital Management's CLBT Position: Q1 2026 in Review

Evolutionary Tree Capital Management increased its Cellebrite (CLBT) stake by 23% in Q1 2026, buying an estimated $510K and bringing the position to 183,473 shares worth $2.53M. The position accounts for 4.75% of the portfolio, ranked #8.

Evolutionary Tree Capital Management first reported a position in CLBT in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.7M in Q4 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Evolutionary Tree Capital Management held 183,473 shares of Cellebrite worth $2.53M as of Q1 2026.
  • Evolutionary Tree Capital Management bought 33,829 Cellebrite shares in Q1 2026, an estimated $510K.
  • Cellebrite made up 4.75% of Evolutionary Tree Capital Management's portfolio in Q1 2026, its #8 holding.
  • Evolutionary Tree Capital Management first reported a position in Cellebrite in Q3 2025 and has held it in 3 quarters since.
  • Evolutionary Tree Capital Management's Cellebrite position peaked at $2.7M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Evolutionary Tree Capital Management's 13F filing for Q1 2026, filed 22 May 2026.